March 1, 2000

1 Min Read
LPJ Issued Patent

LPJ Issued Patent

SEYMOUR, Ill.--LPJ Research Inc. announced it has been issued a patent forits prohormone 19-Nor-4-Androstenediol. The patent, number 6,011,027, wasgranted on the basis that 19-Nor-4-Androstenediol increases 19-nortestosteronelevels in humans. 19-Nor-4-Androstenediol is a close chemical derivative oftestosterone, which is known for its ability to increase lean muscle and bonemass, improve sexual function and promote psychological well being, according toLPJ. For more information, contact LPJ at (217) 687-4138.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like